Since the beginning of this year, the Free Trade Zone has implemented five major projects to introduce new driving force. The number of entities as new driving force in the Zone has increased continuously, and the quality and efficiency of economic development have been further improved. In the first three quarters, a total of 210 reserve national high-tech enterprises were cultivated, and 468 national scientific and technological SMEs, 175 eyas enterprises, and 9 gazelle enterprises were newly recognized. Combining the main responsibilities and main businesses, focusing on key industrial chains, and paying special attention to key fields, the Free Trade Zone has introduced a large number of new driving force projects with a strategic leading effect. Agreements have been signed for a batch of intelligence, biomedicine, and regional headquarters projects such as MEMSIC, Hangcha New Energy, Fosun New Pharmaceutical, New Journey Hospital, and Meijin Energy. In particular, the settlement of the innovative drug R&D base of Hengrui Medicine, one of the Top 20 pharmaceutical companies in the world, indicates that the biomedical industry of the Free Trade Zone has entered into a new era of leading by high-end enterprises and gathered development. The conversion of new and old driving force is continuously accelerating. The incomes of strategic emerging industries, high-tech manufacturing, high-tech service industries, and modern emerging service industries have achieved rapid growth over the same period last year, and the proportion of such incomes in the incomes of similar industries in the zone is far ahead.